| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,042 |
3,308 |
$102K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
334 |
292 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
478 |
432 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
383 |
310 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
48 |
38 |
$820.72 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15 |
14 |
$497.08 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15 |
12 |
$475.87 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
18 |
18 |
$455.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
65 |
62 |
$440.76 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$350.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
31 |
29 |
$288.25 |
| 90633 |
|
13 |
12 |
$278.45 |
| 81003 |
|
347 |
305 |
$205.65 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$76.12 |